Search Results - "Yeshua, Hanny"
-
1
Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
Published in World journal of gastroenterology : WJG (14-03-2017)“…AIM To describe the relationships between non-alcoholic fatty-liver disease(NAFLD) patient’s disease consequences and treatment perceptions, self-efficacy, and…”
Get full text
Journal Article -
2
Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial
Published in World journal of gastroenterology : WJG (21-04-2014)“…AIM:To evaluate the effect of resistance training(RT)on non alcoholic liver disease(NAFLD)patients.METHODS:A randomized clinical trial enrolling NAFLD patients…”
Get full text
Journal Article -
3
Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population
Published in Translational research : the journal of laboratory and clinical medicine (01-03-2015)“…Retrospective studies suggest that coffee consumption may exert beneficial effects in patients with nonalcoholic fatty liver; however, prospective data…”
Get full text
Journal Article -
4
Retinal blood flow velocity in metabolic syndrome
Published in Graefe's archive for clinical and experimental ophthalmology (01-06-2013)“…Background Metabolic syndrome (MetS) is characterized by obesity, insulin resistance, dyslipidemia, and hypertension. The Retinal Function Imager (RFI) is a…”
Get full text
Journal Article -
5
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population
Published in Digestive and liver disease (01-01-2021)“…A growing body of evidence suggests that Non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are associated with cardiovascular disease (CVD)…”
Get full text
Journal Article -
6
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
Published in Alzheimer's & dementia (01-08-2024)“…BACKGROUND We assessed the relationship of liver fibrosis score with incident dementia in a large, national sample. METHODS For this retrospective cohort…”
Get full text
Journal Article -
7
Diagnostic Value of a Computerized Hepatorenal Index for Sonographic Quantification of Liver Steatosis
Published in American journal of roentgenology (1976) (01-04-2009)“…Quantification of liver steatosis is clinically relevant in various liver diseases but cannot be done by conventional sonography, which only provides a…”
Get full text
Journal Article -
8
Reply to: “Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?”
Published in Digestive and liver disease (01-03-2021)Get full text
Journal Article -
9
Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort
Published in European journal of preventive cardiology (01-05-2018)“…Aims The aim of this study was to evaluate the performance of the US Preventive Services Task Force (USPSTF) cholesterol recommendations in a contemporary…”
Get full text
Journal Article -
10
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
Published in World journal of gastroenterology : WJG (07-01-2013)“…To compare noninvasive methods presently used for steatosis detection and quantification in nonalcoholic fatty liver disease (NAFLD). Cross-sectional study of…”
Get full text
Journal Article -
11
Comparison of antidepressant use between adult populations living in urban and rural communities in Israel
Published in Family practice (25-01-2019)“…Depression and anxiety are among the most prevalent disorders in primary care. City dwelling is commonly cited as a risk factor for mental disorders, but…”
Get full text
Journal Article -
12
Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease
Published in Liver international (01-07-2014)“…Background & Aims Non‐alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular disease (CVD) risk. Non‐high‐density lipoprotein…”
Get full text
Journal Article -
13
Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease
Published in Digestive and liver disease (01-05-2017)“…Abstract Background Soluble receptor for advanced glycation end-products (sRAGE) exerts protective metabolic effects. Aims To identify if sRAGE plays a…”
Get full text
Journal Article -
14
Sampling variability of transient elastography according to probe location
Published in European journal of gastroenterology & hepatology (01-06-2011)“…BACKGROUND AND AIMSHeterogeneity of fibrosis throughout the liver has been reported. However, the need for several measurements when using transient…”
Get full text
Journal Article -
15
A Model of Chronic Disease Management: Israeli Physicians' Approach to Cardiovascular Risk Factor Management
Published in World medical and health policy (01-06-2019)“…The prevalence of cardiovascular disease (CVD) death in Israel, a high‐income country that provides universal healthcare, is ~25 percent lower than in the…”
Get full text
Journal Article -
16
Pulmonary Manifestations of Liver Diseases
Published in Seminars in cardiothoracic and vascular anesthesia (01-03-2009)“…Respiratory problems are common in patients with chronic liver diseases. The most common causes are disorders that are not related to liver diseases such as…”
Get full text
Journal Article -
17
European General Practice Research Network (EGPRN)
Published in The European journal of general practice (01-12-2017)Get full text
Journal Article